Dear subscriber, this is a prototype. Please help us with feedback and tips. Just press reply.
The Bio Investments Group and the International Vaccine Institute have agreed on a project to accelerate vaccine manufacturing, clinical trials and workforce development in Africa. The partnership is designed to reduce pharmaceuticals import dependence and strengthen local capabilities for public health emergencies.
The Bio Investments Group, a Swiss-based life sciences company, will lead the investment and transfer of pharmaceutical manufacturing technology, while the International Vaccine Institute will provide scientific guidance and oversee clinical work.
The initiative supports Africa’s climate-health resilience through pharmaceutical industrialisation and regulatory ecosystem growth which will enable local manufacturers to respond faster to outbreaks while building long-term vaccine self-reliance.
Our take: Local manufacturing in Africa is a health security necessity…Read more (2 min)
Africa bears 25% of the global disease burden but hosts just 1.1% of global clinical trials, leaving millions without access to emerging therapies. In an exclusive interview with Healthcare Rising, Dr Henshaw Mandi, an epidemiologist explains that this exclusion delays drug availability and limits local manufacturing.
“You can’t talk about local manufacturing without clinical trials. Trials are where production begins, you need to manufacture small batches to test. If we’re not doing trials here, we’re not part of the value chain. Manufacturing must start with African-led research on African soil.” says Dr. Henshaw.
As Africa faces rising climate-linked health threats, its exclusion from global clinical trials limits access to life-saving innovation and undermines efforts to build resilient, responsive health systems.
Read the full Q&A with Dr. Henshaw, who is the head of the ENABLE Lassa Research Programme and senior epidemiologist at Coalition for Epidemic Preparedness Innovations (CEPI), and the President at TRIFT Alliance…Read more (2 min)
This July, three major events are shaping global health dialogues with a strong presence from Africa. The second Global Digital Health Convening will be held virtually. It builds on WHO commitments to extend digital health strategies, strengthen governance and support equitable, country-led digital transformation in vulnerable health systems.
Later in the month, Algeria will host the International Conference on Pharmaceutical Biotechnology (ICOPB-25), bringing together researchers and innovators to explore new strategies in health research and development and biotechnology.
Looking ahead, the World Health Expo will return to Nairobi this October. Backed by Kenya’s Ministry of Health, the event will spotlight healthcare innovations, sustainability, and partnerships to strengthen East Africa’s position as a regional medical hub.
Find out more…Read more (2 min)
____________________
Japanese maker of medical equipment and clinical tests, Sysmex, has set up an office in Nairobi with an eye on the regional markets.
Jobs
🧑⚕️ Apply to be the Medical Consultant at TSF Health (Kenya)
🧑⚕️ Join Ayrshire & Arran as a Healthcare Support Worker (Uganda)
🧑⚕️ Become the Patient Case Manager at Manaaki Health Care (Ethiopia)
Various
📱 Health partners agree to Advance AI health tech in West Africa
📱 Telecom Egypt and KareXpert launch a digital healthcare platform
💉 Africa’s lawmakers commit to strengthening health manufacturing frameworks
Seen on LinkedIn
Dr Hassan Abdi Hussein, the Africa CDC Somali Region One Health Taskforce Coordinator, says, “Zoonotic diseases, illnesses that pass between animals and humans, are increasing across Africa, posing a growing threat to public health, food security and livelihoods.”____________________